Mission
Harris Health is a public, integrated health system dedicated to improving the health of our communities by delivering high-quality, person-centered care in collaboration with community and academic partners.
Vision
As One Harris Health, our vision is to enable healthier communities through innovative care delivery, collaboration and partnerships.
Values
Collaboration, Accountability, Respect, Excellence, Integrity and Compassion.
Harris Health’s core commitments include:
We Commit to One Harris Health.
As One Harris Health, we will ensure a unified system of health delivery across the care continuum, and in our daily work. One Harris Health is a culture that bridges roles, departments and partnerships, and embraces collaboration in support of community care.
We Commit to Enterprise Risk Management.
As One Harris Health, we will continually survey our internal and external environments for strategic-level risks that will impact our organization and will respond to those risks based on our risk tolerance and appetite.
We Commit to Leveraging Technology.
As One Harris Health, we will implement our strategic technology plan to improve health outcomes, patient safety, efficiency, access and workforce resiliency. We will support our workforce through the changes to processes and roles that new technologies offer through proper training and re-training.
We Commit to Innovation.
As One Harris Health, we will innovate through our people, processes and technologies to improve the health of our communities.
We Commit to Collaboration Inside and Out.
As One Harris Health, we will seek collaboration internally (especially with our workforce) and externally to improve access and the overall health of our communities. We will also seek to expand opportunities for local businesses to learn how to work with Harris Health.
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science.
Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines
*in collaboration with AbbVie
Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder and other mental health conditions. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world.
NeuroStar is the #1 TMS choice of doctors, with over 6.4 million treatments performed to date. It is an advanced treatment for depression and other mental health conditions. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target mental health where it starts — the brain.
Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world.
If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
Please visit NeuroStar.com/Safety for full safety and prescribing information.